143708-33-2 Usage
Description
2-(Chloromethyl)-6-methyl-1,3-benzoxazole is a chemical compound with the molecular formula C9H9ClNO. It is a benzoxazole derivative that contains both a chloromethyl and a methyl group. 2-(CHLOROMETHYL)-6-METHYL-1,3-BENZOXAZOLE is known for its unique structure and reactivity, making it a versatile intermediate in the synthesis of other organic compounds.
Uses
Used in Pharmaceutical Industry:
2-(Chloromethyl)-6-methyl-1,3-benzoxazole is used as a building block for the synthesis of various pharmaceutical compounds. Its unique structure and reactivity allow for the development of new drugs with potential therapeutic applications.
Used in Agrochemical Industry:
In the agrochemical industry, 2-(Chloromethyl)-6-methyl-1,3-benzoxazole serves as a key intermediate in the production of agrochemicals. Its properties contribute to the creation of effective compounds for crop protection and pest control.
Used as a Fluorescent Probe:
2-(Chloromethyl)-6-methyl-1,3-benzoxazole is utilized as a fluorescent probe for detecting metal ions. Its ability to fluoresce in the presence of certain metal ions makes it a valuable tool in analytical chemistry and environmental monitoring.
Investigated for Pharmacological Properties:
Research is being conducted to explore the potential pharmacological properties of 2-(Chloromethyl)-6-methyl-1,3-benzoxazole. Its unique structure may offer new avenues for drug discovery and development in various therapeutic areas.
Check Digit Verification of cas no
The CAS Registry Mumber 143708-33-2 includes 9 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 6 digits, 1,4,3,7,0 and 8 respectively; the second part has 2 digits, 3 and 3 respectively.
Calculate Digit Verification of CAS Registry Number 143708-33:
(8*1)+(7*4)+(6*3)+(5*7)+(4*0)+(3*8)+(2*3)+(1*3)=122
122 % 10 = 2
So 143708-33-2 is a valid CAS Registry Number.
InChI:InChI=1/C9H8ClNO/c1-6-2-3-7-8(4-6)12-9(5-10)11-7/h2-4H,5H2,1H3
143708-33-2Relevant articles and documents
COMPOUNDS HAVING PDE9A INHIBITORY ACTIVITY, AND PHARMACEUTICAL USES THEREOF
-
Paragraph 0124-0125, (2021/10/15)
The present invention provides a compound having a specific chemical structure and having PDE9A inhibitory activity, or a pharmaceutically acceptable salt thereof. The present invention provides a composition containing the compound or a pharmaceutically acceptable salt thereof. The present invention provides a pharmaceutical use, for treating or preventing PDE9A-related diseases, of the compound according to the present invention, a salt thereof, and a composition containing the compound or salt. The present invention also provides a method for treating or preventing PDE9A-related diseases, the method comprising administering an effective amount of the compound according to the present invention, a salt thereof, or a composition containing the compound or salt to a subject in need of treatment.
QUINUCLIDINE DERIVATIVES AND THEIR USE AS MUSCARINIC RECEPTOR ANTAGONISTS FOR THE TREATMENT OF ASTHMA AND CHRONIC OBSTRUCTIVE PULMONARY DISEASE (COPD)
-
Page/Page column 67-68, (2009/12/23)
The invention provides compounds of formula (I) wherein R1, R2, R3, R4, R5, Het1, n, Y and X are as defined in the specification, a process for their preparation, pharmaceutical compositions containing them, a process for preparing pharmaceutical compositions, their use in therapy and intermediates of use in their preparation.
